Greater collaboration amongst all stakeholders, including suppliers, customers, logistics providers, and others is needed to develop resilient supply chains for effective distribution of vaccines globally. This session discusses the importance of such partnerships and the role of technology in improving supply chain flexibility to address random and high-impact events.
Speakers:
Mahima Datla, Managing Director & Chief Executive Officer, Vaccines & Branded Formulations, Biological E Limited
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon
Robin Davies, Head, Indo-Pacific Centre for Health Security, Government of Australia
Moderator:
Neeraj Jain, Country Director, PATH India
